In September 2025, RFK Jr.’s hand-picked members of the CDC’s Advisory Committee on Immunization Practices (ACIP) met, in part, to discuss the hepatitis B vaccine. During that meeting, the group decided to recommend delaying the birth dose of hepatitis B vaccine until at least 2 months of age in babies whose mothers weren’t infected with the virus. The routine hepatitis B vaccine birth dose, which was first recommended in the United States in 1991, had virtually eliminated the disease in children, and, consequently, virtually eliminated the chance that these children would go on to develop cirrhosis or liver cancer. RFK Jr.’s ACIP was disbanded in March 2026 due to ongoing litigation.
In October 2026, researchers from the Massachusetts General Hospital studied what would happen to the incidence of chronic hepatitis B virus infections among a theoretical birth cohort of 3.6 million children if, instead of the universal birth dose recommendations, parents chose either a delayed vaccine strategy or a shared clinical decision-making strategy as had been proposed by RFK Jr.’s ACIP (Mohareb AM, Ganapathi L, Dugdale CM, et al. “Projected Effect of 2026 Federal Changes to the Childhood Immunization Schedule on Chronic Hepatitis B Virus Infections in the United States.” Ann Intern Med. 2026 Oct 20. doi:10.7326/ANNALS-S-26-02135).
Researchers found that, compared with the universal birth dose strategy, the deferred vaccine strategy would increase the risk of chronic hepatitis B infection by 19%, and the shared clinical decision-making strategy would increase the risk by 83%. The authors concluded, “Proposed policy changes for vaccination through shared clinical decision-making are projected to result in an 83% increase in childhood hepatitis B infections…Policymakers should reimplement recommendations for universal birth-dose vaccination.”
In September 2025, RFK Jr.’s hand-picked members of the CDC’s Advisory Committee on Immunization Practices (ACIP) met, in part, to discuss the hepatitis B vaccine. During that meeting, the group decided to recommend delaying the birth dose of hepatitis B vaccine until at least 2 months of age in babies whose mothers weren’t infected with the virus. The routine hepatitis B vaccine birth dose, which was first recommended in the United States in 1991, had virtually eliminated the disease in children, and, consequently, virtually eliminated the chance that these children would go on to develop cirrhosis or liver cancer. RFK Jr.’s ACIP was disbanded in March 2026 due to ongoing litigation.
In October 2026, researchers from the Massachusetts General Hospital studied what would happen to the incidence of chronic hepatitis B virus infections among a theoretical birth cohort of 3.6 million children if, instead of the universal birth dose recommendations, parents chose either a delayed vaccine strategy or a shared clinical decision-making strategy as had been proposed by RFK Jr.’s ACIP (Mohareb AM, Ganapathi L, Dugdale CM, et al. “Projected Effect of 2026 Federal Changes to the Childhood Immunization Schedule on Chronic Hepatitis B Virus Infections in the United States.” Ann Intern Med. 2026 Oct 20. doi:10.7326/ANNALS-S-26-02135).
Researchers found that, compared with the universal birth dose strategy, the deferred vaccine strategy would increase the risk of chronic hepatitis B infection by 19%, and the shared clinical decision-making strategy would increase the risk by 83%. The authors concluded, “Proposed policy changes for vaccination through shared clinical decision-making are projected to result in an 83% increase in childhood hepatitis B infections…Policymakers should reimplement recommendations for universal birth-dose vaccination.”